Francesca Gilli

Department of Neurology, Geisel School of Medicine at Dartmouth

Affiliated withGeisel School of Medicine at Dartmouth Geisel School of Medicine & Dartmouth-Hitchcock Medical Center Dartmouth-Hitchcock Medical Center

Research Area

Biography

Francesca Gilli has not added Biography.
If you are Francesca Gilli and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3	Year
Publication title Cited by 21	2016
Publication title Cited by 3	2019
Publication title Cited by 8	2020

Other Publications

Article	Year
Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs. Brain : a journal of neurology\| PubMed ID: 14607790	2004
Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosis. Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology\| PubMed ID: 15771557	2004
Anti-interferon-beta neutralising activity is not entirely mediated by antibodies. Journal of neuroimmunology\| PubMed ID: 17950468	2007
Development of a bioassay for quantification of neutralising antibodies against human interferon-beta in mouse sera. Journal of immunological methods\| PubMed ID: 18558408	2008
Interferon-beta responders and non-responders. A biological approach. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology\| PubMed ID: 18690496	2008
Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica. Journal of neuroimmunology\| PubMed ID: 19850359	2009
Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta. Journal of immunological methods\| PubMed ID: 19857496	2010
Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. PloS one\| PubMed ID: 20126412	2010
Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis. Archives of neurology\| PubMed ID: 20142519	2010
Aggregated recombinant human interferon Beta induces antibodies but no memory in immune-tolerant transgenic mice. Pharmaceutical research\| PubMed ID: 20499141	2010
Acute-phase proteins investigation based on lectins affinity capture prior to 2-DE separation: application to serum from multiple sclerosis patients. Electrophoresis\| PubMed ID: 20715125	2010
Role of differential expression of interferon receptor isoforms on the response of multiple sclerosis patients to therapy with interferon beta. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research\| PubMed ID: 20874250	2010
One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients. Journal of neurology\| PubMed ID: 21153733	2011
Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis. Archives of neurology\| PubMed ID: 21403007	2011
Oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice. Pharmaceutical research\| PubMed ID: 21544687	2011
Immunogenicity of recombinant human interferon beta interacting with particles of glass, metal, and polystyrene. Journal of pharmaceutical sciences\| PubMed ID: 21918983	2012
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 22562951	2012
Chemokine biomarkers in central nervous system tissue and cerebrospinal fluid in the Theiler's virus model mirror those in multiple sclerosis. Cytokine\| PubMed ID: 26141421	2015
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response. Journal of neurovirology\| PubMed ID: 26260496	2016
The effect of B-cell depletion in the Theiler's model of multiple sclerosis. Journal of the neurological sciences\| PubMed ID: 26671084	2015
High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis. PloS one\| PubMed ID: 27467829	2016
Treatment of Theiler's virus-induced demyelinating disease with teriflunomide. Journal of neurovirology\| PubMed ID: 28913765	2017
Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis. Journal of neuroimmunology\| PubMed ID: 29153606	2017
Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta. International immunopharmacology\| PubMed ID: 29960044	2018
Clinical utility of a molecular signature in inflammatory demyelinating disease. Neurology(R) neuroimmunology & neuroinflammation\| PubMed ID: 30568998	2019
Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis. Journal of neuroinflammation\| PubMed ID: 31118079	2019
Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis. Frontiers in immunology\| PubMed ID: 31428102	2019